Sino Biological

IPO

Sino Biological is a biotech company in Beijing, China, founded in 2007. It has raised $29.0M across 1 round, most recently a $29.0M Series A in May 2018.

Global Leader in Recombinant Technology for Life Science

Headquarters
Beijing
Employees
501–1000
Founded
2007
Business Model
B2B
Total Funding
$29.0M
Last Round
$29.0M Series AMay 2018
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Sino Biological is an international reagent supplier and service provider specializing in independently developed recombinant proteins, antibodies, and cDNA clones for life science research. The company serves academic institutions, biotech firms, and pharmaceutical companies with one-stop technical services, including pre-clinical production for monoclonal antibody drug candidates, and operates from headquarters in Beijing with subsidiaries and production facilities in the United States, Europe, and Japan. Sino Biological employs over 900 research staff, including 230+ with master's or PhD degrees, across more than 279,800 sq ft of lab and office space.

Summary

It lists 501–1000 employees. It has raised $29.0M in total across 1 round, most recently a $29.0M Series A round in May 2018. Investors include Qiming VP.

Funding & Exit History

Data from Indexed.vcUpdated
IPOAug 2021
$681.0M

Sign up to see all 2 events

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sino Biological on Indexed.vc
<a href="https://indexed.vc/companies/sino-biological"><img src="https://indexed.vc/api/badge/company/sino-biological" alt="Sino Biological on Indexed.vc" width="260" height="76" /></a>